"Lurasidone Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.
| Descriptor ID |
D000069056
|
| MeSH Number(s) |
D02.886.675.414 D03.383.129.708.414 D03.633.100.513.437
|
| Concept/Terms |
SM 13496- SM 13496
- 13496, SM
- SM13496
- SM-13,496
- SM 13,496
- SM13,496
- SM-13496
Lurasidone- Lurasidone
- N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide
|
Below are MeSH descriptors whose meaning is more general than "Lurasidone Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Lurasidone Hydrochloride".
This graph shows the total number of publications written about "Lurasidone Hydrochloride" by people in this website by year, and whether "Lurasidone Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 2 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lurasidone Hydrochloride" by people in Profiles.
-
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Res. 2021 05; 189:105055.
-
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. Eur Neuropsychopharmacol. 2019 09; 29(9):971-985.
-
Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 08; 103:244-251.
-
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatr Scand. 2018 09; 138(3):196-222.
-
The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis. BMC Psychiatry. 2017 11 21; 17(1):373.
-
Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders. Expert Opin Drug Saf. 2018 Feb; 17(2):197-205.
-
Lurasidone-Induced Dystonia. Prim Care Companion CNS Disord. 2017 Jun 29; 19(3).
-
A review of FDA-approved treatment options in bipolar depression. CNS Spectr. 2013 Dec; 18 Suppl 1:4-20; quiz 21.
-
Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol. 2013 Aug; 69(8):1497-509.